Geron abandons stem cell therapy as treatment for paralysis
16 November 2011
Professor John Martin (¹û¶³Ó°Ôº Cardiovascular Medicine) comments on the announcement by biotech company Geron that it will abandon the first ever stem cell trial to treat paralysis.